PKAN: Phase II Study of a Novel Vitamin Metabolite (CoA-Z) for Pantothenate Kinase Associated Neurodegeneration

Home » Clinical Trials » PKAN: Phase II Study of a Novel Vitamin Metabolite (CoA-Z) for Pantothenate Kinase Associated Neurodegeneration

Research area:

Rare disease

Disease:

Pantothenate kinase associated neurodegeneration

Intervention:

Therapeutics – small molecules

Phase:

Phase II

Intervention

Therapeutics – small molecules

Funding awarded to

University College London Great Ormond’s Street Hospital

Planned trial start and expected end date

December 2019 to March 2026